2016年8月
A Phase II Clinical Trial Evaluating the Preventive Effectiveness of Lactobacillus Vaginal Suppositories in Patients with Recurrent Cystitis
ACTA MEDICA OKAYAMA
- 巻
- 70
- 号
- 4
- 開始ページ
- 299
- 終了ページ
- 302
- 記述言語
- 英語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.18926/AMO/54508
- 出版者・発行元
- OKAYAMA UNIV MED SCHOOL
Urinary tract infections (UTIs) are the most common bacterial infections in women, and many patients experience frequent recurrence. The aim of this report is to introduce an on-going prospective phase II clinical trial performed to evaluate the preventive effectiveness of Lactobacillus vaginal suppositories for prevention of recurrent cystitis. Patients enrolled in this study are administered vaginal suppositories containing the GAI 98322 strain of Lactobacillus crispatus every 2 days or 3 times a week for one year. The primary endpoint is recurrence of cystitis and the secondary endpoints are adverse events. Recruitment began in December 2013 and target sample size is 20 participants.
- リンク情報
- ID情報
-
- DOI : 10.18926/AMO/54508
- ISSN : 0386-300X
- PubMed ID : 27549677
- Web of Science ID : WOS:000384748600012